Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tvardi Therapeutics, Inc. - Common Stock
(NQ:
TVRD
)
4.550
-0.100 (-2.15%)
Streaming Delayed Price
Updated: 11:20 AM EST, Nov 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tvardi Therapeutics, Inc. - Common Stock
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
October 31, 2025
From
The Schall Law Firm
Via
Business Wire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
October 30, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
October 26, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Rosen Law Firm Encourages Tvardi Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – TVRD
October 24, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
October 13, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Tvardi Therapeutics Provides Update on Preliminary Data from Phase 2 REVERT Trial in Idiopathic Pulmonary Fibrosis
October 13, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
August 21, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
August 14, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
July 15, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
May 27, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics to Participate in Upcoming Investor Conferences
May 20, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update
May 13, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference
May 06, 2025
From
Tvardi Therapeutics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.